Skip to main content
. 2018 Jan 8;18:51. doi: 10.1186/s12885-017-3857-5

Fig. 2.

Fig. 2

Kaplan-Meier plots of (a) relapse-free survival and (b) overall survival in propensity score matched patients with early breast cancer receiving adjuvant trastuzumab with or without chemotherapy